Oscar Health (NYSE:OSCR) Stock Price Up 4.1% - Time to Buy?

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) rose 4.1% on Wednesday . The stock traded as high as $15.18 and last traded at $14.98. Approximately 739,484 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 2,250,402 shares. The stock had previously closed at $14.39.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OSCR. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and lowered their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target on the stock. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price on the stock. Finally, Piper Sandler reiterated an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $21.56.

Oscar Health Stock Performance

The company has a fifty day moving average price of $15.24 and a two-hundred day moving average price of $16.94. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of -254.96 and a beta of 1.70. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the business posted ($0.29) EPS. The business's revenue for the quarter was up 68.3% on a year-over-year basis. As a group, equities research analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Activity

In other news, insider Mario Schlosser sold 6,516 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $117,809.28. Following the sale, the insider now owns 81,962 shares in the company, valued at $1,481,872.96. The trade was a 7.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. Insiders own 25.11% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Principal Financial Group Inc. increased its position in Oscar Health by 40.8% in the 2nd quarter. Principal Financial Group Inc. now owns 26,266 shares of the company's stock worth $416,000 after purchasing an additional 7,616 shares during the last quarter. Rhumbline Advisers increased its holdings in Oscar Health by 8.7% in the second quarter. Rhumbline Advisers now owns 270,341 shares of the company's stock worth $4,277,000 after buying an additional 21,717 shares during the last quarter. TD Asset Management Inc lifted its stake in Oscar Health by 35.9% in the second quarter. TD Asset Management Inc now owns 669,684 shares of the company's stock valued at $10,594,000 after acquiring an additional 176,884 shares during the last quarter. Victory Capital Management Inc. grew its position in Oscar Health by 114.1% in the second quarter. Victory Capital Management Inc. now owns 40,976 shares of the company's stock worth $648,000 after acquiring an additional 21,840 shares in the last quarter. Finally, Arizona State Retirement System grew its position in Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock worth $602,000 after acquiring an additional 1,351 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.